Company Filing History:
1 out of 8,384 
1 out of 702 
Years Active: 2024
Title: Innovator Kun Xu: Pioneering Cancer Therapeutics
Introduction
Kun Xu, an innovative inventor based in Dorchester, MA, has made significant strides in the field of cancer research through his patented work. His contributions emphasize the importance of developing therapeutic solutions to combat cancer invasion and metastasis.
Latest Patents
Kun Xu holds a noteworthy patent titled "Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis." This patent outlines the creation of derivatized agelastatin compounds, which are aimed at the treatment, prevention, or delay of cancer. The method involves administering a therapeutically effective amount of these compounds, including their pharmaceutically acceptable salts, to individuals in need. Additionally, the patent includes methods for synthesizing these vital compounds.
Career Highlights
Throughout his career, Kun Xu has collaborated with esteemed institutions, notably the Massachusetts Institute of Technology (MIT) and Tufts Medical Center. His role in these institutions underscores his commitment to advancing cancer research and therapeutic methods.
Collaborations
Kun Xu has worked alongside talented professionals such as Mohammad Movassaghi and Alyssa H Antropow. These collaborations highlight the collective efforts in the pursuit of innovative solutions within the scientific community.
Conclusion
In summary, Kun Xu's contributions through his patent represent a significant advancement in the search for effective cancer treatments. His work reflects the ongoing commitment of researchers and inventors to improve healthcare outcomes and foster innovation in the medical field.